한글목차

세계 신경독 시장의 미래는 병원, 전문 클리닉, 피부과 클리닉의 각 시장에서의 기회로 인해 유망합니다. 세계 신경독 시장은 2025년부터 2031년까지 연평균 복합 성장률(CAGR) 10.0%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 미용 성형에 대한 수요 증가, 치료 용도의 대중화, 얼굴 회춘을 위한 비수술적 대안에 대한 선호도 증가입니다.

• Lucintel은 제품 유형별로는 보톡스가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상하고 있습니다.
• 최종사용자 카테고리에서는 병원이 가장 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 규모가 큰 지역으로 남아 있습니다.

신경독 시장의 전략적 성장 기회

신경독 시장은 주요 응용 분야에서 몇 가지 전략적 성장 기회를 제공합니다. 이러한 기회를 파악하고 활용하면 기술 발전과 소비자 선호도 변화로 인해 시장이 계속 진화하는 가운데 시장 확장을 촉진하고 환자 치료 결과를 개선할 수 있습니다.

• 신흥 시장 진출: 인도, 중국 등 신흥 시장 진출은 수요 증가와 의료 인프라 개선으로 인해 큰 성장 기회가 될 수 있습니다. 기업들은 이들 지역에서 신경독 치료에 대한 인식과 접근성이 높아지는 것을 활용하여 시장 성장을 가속할 수 있습니다.
• 장기 지속형 제제 개발: 장기 지속형 신경독 제제의 개발은 환자의 만족도와 순응도를 높일 수 있는 기회를 제공합니다. 이러한 제제는 주사의 빈도를 줄이고 편의성과 치료 결과를 향상시켜 시장 성장을 가속하는 요인으로 작용할 수 있습니다.
• 병용요법의 발전: 신경독을 피부 필러 및 물리치료와 같은 다른 치료와 통합하는 병용요법의 발전은 환자에게 종합적인 솔루션을 제공합니다. 이러한 접근 방식은 치료 효과를 높이고 시장 기회를 확대할 수 있습니다.
• 미용용도에 대한 관심: 비수술적 미용 시술에 대한 수요 증가는 전략적 성장 기회로 작용할 수 있습니다. 신경독의 미용용도를 확대함으로써 미용 시장 점유율을 확대하고 수익 성장을 가속할 수 있습니다.
• R&D 투자: 새로운 적응증을 발견하고 기존 신경독을 개선하기 위한 R&D 투자는 큰 성장 잠재력을 가지고 있습니다. 약물의 제형, 전달 방법, 치료 용도의 혁신은 제품을 차별화하고 시장 확대의 원동력이 될 수 있습니다.

이러한 전략적 성장 기회는 치료 옵션을 확대하고 환자 경험을 개선하며 기술 혁신을 촉진함으로써 신경독 시장을 형성하고 있습니다. 신흥국 시장 진출, 오래 지속되는 제형 개발, 미용 용도에 대한 집중은 시장 성장의 주요 촉진요인입니다. 연구개발에 대한 투자는 혁신과 차별화를 더욱 촉진하여 역동적이고 진화하는 신경독 시장에 기여하고 있습니다.

신경독 시장 성장 촉진요인 및 과제

신경독 시장은 기술 발전, 규제 요인, 경제적 고려사항 등 다양한 시장 성장 촉진요인 및 과제에 영향을 받습니다. 이러한 요인을 이해하는 것은 시장을 탐색하고 성장 기회를 파악하는 데 필수적입니다.

신경독 시장 성장 촉진요인은 다음과 같습니다:

1. 기술 발전: 신경독 제제 및 전달 시스템의 기술 발전이 시장 성장의 원동력이 되고 있습니다. 지속시간이 긴 제제 및 무침 주사법 등의 기술 혁신은 치료 효과와 환자의 편안함을 향상시키고 시장 기회를 확대하고 있습니다.

2. 미용 치료에 대한 수요 증가: 주름 개선, 얼굴 윤곽 성형 등 비수술적 미용 시술에 대한 수요 증가가 큰 원동력이 되고 있습니다. 이러한 추세는 저침습적 미용치료에 대한 소비자의 선호가 확산되고 있음을 반영하며, 신경독 시장을 견인하고 있습니다.

3. 치료 적응증 확대: 신경장애 및 만성질환의 새로운 치료 등 신경독의 치료 적응증 확대가 시장 성장의 원동력이 되고 있습니다. 이를 통해 적용 범위가 확대되어 미충족 의료 수요에 대응할 수 있습니다.

4. 연구개발 투자 증가: 연구개발 투자 증가는 혁신을 촉진하고 시장 성장을 주도하고 있습니다. 기업들은 진화하는 환자의 니즈와 시장 수요를 충족시키기 위해 새로운 신경독 제품 개발 및 기존 제품의 개선에 집중하고 있습니다.

5. 규제 승인 강화: 주요 시장의 규제 프레임워크가 강화되고 승인 절차가 신속해짐에 따라 새로운 신경독의 도입이 촉진되고 있습니다. 이러한 개선은 시장 진입을 간소화하고 기술 혁신을 지원함으로써 시장 확대에 기여하고 있습니다.

신경독 시장의 과제는 다음과 같습니다:

1. 높은 기술 혁신 비용: 새로운 신경독 개발 및 상용화에 따른 높은 비용은 시장 진입 및 채택에 장벽이 될 수 있습니다. 고비용의 연구개발 과정은 혁신적인 치료법에 대한 접근성을 제한하고 시장 성장에 영향을 미칠 수 있습니다.

2. 규제 장애물: 복잡한 규제 요건을 극복하고 새로운 신경독 제제의 승인을 얻는 것은 어렵습니다. 엄격한 규제와 긴 승인 절차는 시장 진입을 지연시키고 경쟁력에 영향을 미칠 수 있습니다.

3. 시장 경쟁: 기존 기업과 신규 진출기업 간의 치열한 경쟁이 시장 역학에 영향을 미칠 수 있습니다. 기업은 혁신과 전략적 포지셔닝을 통해 제품을 차별화하고 경쟁력을 유지해야 합니다.

신경독 시장에 영향을 미치는 시장 성장 촉진요인 및 과제는 기술, 경제, 규제 요인이 복잡하게 얽혀 있음을 반영합니다. 기술 발전, 미용 치료에 대한 수요 증가, R&D 투자 증가와 같은 촉진요인은 시장 성장을 가속하는 반면, 높은 비용, 규제 장벽, 시장 경쟁과 같은 과제는 시장 성장을 저해하는 요인으로 작용하고 있습니다. 신경독 시장을 발전시키고 지속적인 발전을 이루기 위해서는 시장 성장 촉진요인 및 과제를 활용하면서 이러한 과제를 해결하는 것이 매우 중요합니다.

목차

제1장 주요 요약

제2장 세계의 신경독 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 신경독 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 신경독 시장, 제품 유형별
  • Botox
  • Dysport
  • Xeomin
  • 기타
• 세계의 신경독 시장, 용도별
  • 치료
  • 미용
• 세계의 신경독 시장, 최종 용도별
  • 병원
  • 전문 클리닉
  • 피부과 클리닉
  • 기타

제4장 시장 동향과 예측 분석(2019-2031년) : 지역별

• 세계의 신경독 시장, 지역별
• 북미의 신경독 시장
• 유럽의 신경독 시장
• 아시아태평양의 신경독 시장
• 기타 지역의 신경독 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 신경독 시장 성장 기회, 제품 유형별
  • 세계의 신경독 시장 성장 기회, 용도별
  • 세계의 신경독 시장 성장 기회, 최종 용도별
  • 세계의 신경독 시장 성장 기회, 지역별
• 세계 신경독 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 신경독 시장 능력 확대
  • 세계 신경독 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 주요 기업 개요

• AbbVie
• Galderma
• Ipsen
• Daewoong Pharmaceutical
• Supernus Pharmaceuticals
• Merz Pharma
• Hugel
• Evolus
• Medytox
• Croma-Pharma

영문목차

The future of the global neurotoxin market looks promising with opportunities in the hospital, specialty clinic, and dermatology clinic markets. The global neurotoxin market is expected to grow with a CAGR of 10.0% from 2025 to 2031. The major drivers for this market are the rise in demand for cosmetic procedures, the increasing prevalence of therapeutic applications, and the growing preference for non-surgical options for facial rejuvenation.

• Lucintel forecasts that, within the product type category, botox is expected to witness the highest growth over the forecast period.
• Within the end-use category, the hospital is expected to witness the highest growth.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Neurotoxin Market

The neurotoxin market is witnessing several emerging trends that are shaping its future. These trends include advancements in drug development, increased application areas, and evolving patient preferences. Understanding these trends is crucial for stakeholders to navigate the changing landscape and capitalize on growth opportunities.

• Expansion of Therapeutic Indications: The trend towards expanding therapeutic indications for neurotoxins is notable. Beyond traditional uses in aesthetic medicine, neurotoxins are increasingly used for conditions like chronic migraines, spasticity, and overactive bladder. This expansion is broadening the market and providing new treatment options for a range of neurological disorders.
• Development of Novel Formulations: Novel formulations of neurotoxins, including longer-lasting products and those with reduced side effects, are emerging. These innovations aim to improve patient outcomes and enhance the convenience of treatments. Longer-lasting formulations reduce the need for frequent injections, improving patient compliance and satisfaction.
• Growth of Aesthetic Applications: The growth of aesthetic applications for neurotoxins is a significant trend. Increased demand for non-surgical cosmetic procedures, such as wrinkle reduction and facial contouring, is driving market expansion. This trend reflects a broader societal shift towards minimally invasive cosmetic treatments and enhances the market for neurotoxins.
• Increased Use in Combination Therapies: There is a growing trend towards using neurotoxins in combination with other therapies, such as dermal fillers or physical therapy. Combination treatments offer synergistic effects and improved patient outcomes. This trend is expanding the range of applications for neurotoxins and providing more comprehensive solutions for various conditions.
• Advancements in Delivery Methods: Advancements in delivery methods, including needle-free injection systems and advanced formulations, are reshaping the neurotoxin market. These innovations aim to enhance patient comfort, reduce discomfort, and improve the precision of treatments. New delivery methods are likely to increase patient acceptance and drive market growth.

These emerging trends are reshaping the neurotoxin market by expanding treatment options, improving patient experiences, and driving market growth. The focus on novel formulations, increased aesthetic applications, and advancements in delivery methods reflect a shift towards more effective and patient-friendly solutions. The integration of neurotoxins in combination therapies and the expansion of therapeutic indications further contribute to market evolution and innovation.

Recent Developments in the Neurotoxin Market

Recent developments in the neurotoxin market are marked by advancements in drug approvals, new product launches, and evolving treatment applications. These developments highlight the dynamic nature of the market and its response to the growing demand for both medical and aesthetic neurotoxin applications.

• New Product Approvals: Recent approvals of new neurotoxin products, such as new formulations and extended-release versions, have expanded treatment options. These new products address various medical conditions and aesthetic needs, offering improved efficacy and patient outcomes.
• Regulatory Changes: Regulatory changes in key markets have facilitated faster approvals and market entry for innovative neurotoxins. Enhanced regulatory frameworks in countries like China and Japan are supporting the introduction of new therapies and improving access to neurotoxin treatments.
• Expansion of Market Players: The market is seeing increased competition with the entry of new players and the expansion of existing ones. Companies are focusing on differentiating their products through innovation, improved formulations, and expanded indications to capture market share.
• Technological Innovations: Technological innovations, such as advanced delivery systems and needle-free injection methods, are transforming the neurotoxin market. These innovations enhance the precision of treatments, reduce discomfort, and improve patient compliance.
• Growing Consumer Awareness: Growing consumer awareness of neurotoxin treatments for both medical and aesthetic purposes is driving market growth. Increased education and marketing efforts are leading to higher demand for neurotoxin products and procedures.

These recent developments are driving growth in the neurotoxin market by expanding treatment options, improving regulatory processes, and increasing competition. Innovations in product formulations and delivery methods are enhancing patient experiences while growing consumer awareness is boosting market demand. These factors collectively contribute to a dynamic and evolving neurotoxin market.

Strategic Growth Opportunities for Neurotoxin Market

The neurotoxin market presents several strategic growth opportunities across key applications. Identifying and leveraging these opportunities can drive market expansion and improve patient outcomes, as the market continues to evolve with technological advancements and changing consumer preferences.

• Expansion into Emerging Markets: Expanding into emerging markets, such as India and China, offers significant growth opportunities due to increasing demand and improving healthcare infrastructure. Companies can capitalize on growing awareness and access to neurotoxin treatments in these regions to drive market growth.
• Development of Long-Lasting Formulations: Developing long-lasting neurotoxin formulations presents an opportunity to enhance patient satisfaction and compliance. These formulations reduce the frequency of injections, offering convenience and improving treatment outcomes, thus driving market growth.
• Advancements in Combination Therapies: Advancing combination therapies that integrate neurotoxins with other treatments, such as dermal fillers or physical therapy, provide comprehensive solutions for patients. This approach enhances the efficacy of treatments and expands market opportunities.
• Focus on Aesthetic Applications: The growing demand for non-surgical aesthetic procedures represents a strategic growth opportunity. Expanding the range of aesthetic applications for neurotoxins can capture a larger share of the cosmetic market and drive revenue growth.
• Investment in Research and Development: Investing in research and development to discover new indications and improve existing neurotoxins offers significant growth potential. Innovations in drug formulations, delivery methods, and therapeutic applications can differentiate products and drive market expansion.

These strategic growth opportunities are shaping the neurotoxin market by expanding treatment options, improving patient experiences, and driving innovation. Expanding into emerging markets, developing long-lasting formulations, and focusing on aesthetic applications are key drivers of market growth. Investments in research and development further support innovation and differentiation, contributing to a dynamic and evolving neurotoxin market.

Neurotoxin Market Driver and Challenges

The neurotoxin market is influenced by various drivers and challenges, including technological advancements, regulatory factors, and economic considerations. Understanding these factors is essential for navigating the market and identifying growth opportunities.

The factors responsible for driving the neurotoxin market include:

1. Technological Advancements: Technological advancements in neurotoxin formulations and delivery systems are driving market growth. Innovations such as longer-lasting formulations and needle-free injection methods enhance treatment efficacy and patient comfort, expanding market opportunities.

2. Growing Demand for Aesthetic Treatments: The increasing demand for non-surgical aesthetic procedures, such as wrinkle reduction and facial contouring, is a significant driver. This trend reflects broader consumer preferences for minimally invasive cosmetic treatments, boosting the neurotoxin market.

3. Expansion of Therapeutic Indications: The expansion of therapeutic indications for neurotoxins, including new treatments for neurological disorders and chronic conditions, is driving market growth. This broadens the application range and addresses unmet medical needs.

4. Increased Investment in R&D: Increased investment in research and development is fostering innovation and driving market growth. Companies are focusing on developing new neurotoxin products and improving existing ones to meet evolving patient needs and market demands.

5. Enhanced Regulatory Approvals: Enhanced regulatory frameworks and faster approval processes in key markets are facilitating the introduction of new neurotoxins. These improvements streamline market entry and support innovation, contributing to market expansion.

Challenges in the neurotoxin market are:

1. High Costs of Innovation: The high costs associated with developing and commercializing new neurotoxins can be a barrier to market entry and adoption. Expensive research and development processes may limit access to innovative treatments and impact market growth.

2. Regulatory Hurdles: Navigating complex regulatory requirements and obtaining approvals for new neurotoxin products can be challenging. Stringent regulations and lengthy approval processes may delay market entry and affect competitive dynamics.

3. Market Competition: Intense competition among established players and new entrants can impact market dynamics. Companies must differentiate their products through innovation and strategic positioning to maintain a competitive edge.

The drivers and challenges impacting the neurotoxin market reflect a complex interplay of technological, economic, and regulatory factors. While drivers such as technological advancements, growing demand for aesthetic treatments, and increased R&D investment are fostering market growth, challenges like high costs, regulatory hurdles, and market competition present obstacles. Addressing these challenges while leveraging the drivers is crucial for advancing the neurotoxin market and achieving sustained development.

List of Neurotoxin Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies neurotoxin companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurotoxin companies profiled in this report include-

• AbbVie
• Galderma
• Ipsen
• Daewoong Pharmaceutical
• Supernus Pharmaceuticals
• Merz Pharma
• Hugel
• Evolus
• Medytox
• Croma-Pharma

Neurotoxin by Segment

The study includes a forecast for the global neurotoxin market by product type, application, end use, and region.

Neurotoxin Market by Product Type [Analysis by Value from 2019 to 2031]:

• Botox
• Dysport
• Xeomin
• Others

Neurotoxin Market by Application [Analysis by Value from 2019 to 2031]:

• Therapeutic
• Aesthetic

Neurotoxin Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Specialty Clinics
• Dermatology Clinics
• Others

Neurotoxin Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Neurotoxin Market

The neurotoxin market is evolving rapidly with significant advancements across different regions. These developments reflect innovations in medical and cosmetic applications, regulatory changes, and increasing market demand. Key countries like the United States, China, Germany, India, and Japan are experiencing unique shifts in this dynamic sector.

• United States: In the U.S., recent developments include the approval of new neurotoxin products for both medical and aesthetic applications. The FDA has granted new indications for existing neurotoxins and greenlit innovative treatments for chronic migraines and spasticity. Increased competition among major players like Allergan, Revanche, and Ipsen is driving advancements and expanding treatment options, enhancing patient choice.
• China: China is experiencing growth in the neurotoxin market with increased local production and regulatory approvals. The introduction of domestically produced neurotoxins aims to meet rising demand for both cosmetic and therapeutic uses. The Chinese government is also enhancing its regulatory framework, facilitating faster approval processes and encouraging innovation in neurotoxin applications.
• Germany: In Germany, advancements are marked by the integration of new neurotoxin products into healthcare systems. Recent approvals include neurotoxins for treating neurological disorders and enhancing aesthetic procedures. Germany's rigorous healthcare standards ensure high-quality products and foster an environment of innovation, with a focus on expanding the therapeutic indications of existing neurotoxins.
• India: India's neurotoxin market is expanding with increased awareness and availability of treatments. Recent developments include the introduction of cost-effective neurotoxin products and improved distribution networks. Growing interest in cosmetic procedures and advancements in medical applications are driving market growth, supported by both local and international pharmaceutical companies.
• Japan: In Japan, recent developments include the launch of new neurotoxin products and advancements in treatment techniques. Japanese regulatory bodies are working to streamline approval processes for innovative neurotoxin treatments. The market is also seeing increased adoption of neurotoxins for aesthetic and therapeutic purposes, driven by technological advancements and growing patient demand.

Features of the Global Neurotoxin Market

Market Size Estimates: Neurotoxin market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Neurotoxin market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Neurotoxin market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the neurotoxin market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurotoxin market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the neurotoxin market by product type (botox, dysport, xeomin, and others), application (therapeutic and aesthetic), end use (hospitals, specialty clinics, dermatology clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neurotoxin Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Neurotoxin Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Neurotoxin Market by Product Type
  • 3.3.1: Botox
  • 3.3.2: Dysport
  • 3.3.3: Xeomin
  • 3.3.4: Others
• 3.4: Global Neurotoxin Market by Application
  • 3.4.1: Therapeutic
  • 3.4.2: Aesthetic
• 3.5: Global Neurotoxin Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Specialty Clinics
  • 3.5.3: Dermatology Clinics
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Neurotoxin Market by Region
• 4.2: North American Neurotoxin Market
  • 4.2.1: North American Market by Product Type: Botox, Dysport, Xeomin, and Others
  • 4.2.2: North American Market by End Use: Hospitals, Specialty Clinics, Dermatology Clinics, and Others
• 4.3: European Neurotoxin Market
  • 4.3.1: European Market by Product Type: Botox, Dysport, Xeomin, and Others
  • 4.3.2: European Market by End Use: Hospitals, Specialty Clinics, Dermatology Clinics, and Others
• 4.4: APAC Neurotoxin Market
  • 4.4.1: APAC Market by Product Type: Botox, Dysport, Xeomin, and Others
  • 4.4.2: APAC Market by End Use: Hospitals, Specialty Clinics, Dermatology Clinics, and Others
• 4.5: ROW Neurotoxin Market
  • 4.5.1: ROW Market by Product Type: Botox, Dysport, Xeomin, and Others
  • 4.5.2: ROW Market by End Use: Hospitals, Specialty Clinics, Dermatology Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Neurotoxin Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Neurotoxin Market by Application
  • 6.1.3: Growth Opportunities for the Global Neurotoxin Market by End Use
  • 6.1.4: Growth Opportunities for the Global Neurotoxin Market by Region
• 6.2: Emerging Trends in the Global Neurotoxin Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Neurotoxin Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurotoxin Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: AbbVie
• 7.2: Galderma
• 7.3: Ipsen
• 7.4: Daewoong Pharmaceutical
• 7.5: Supernus Pharmaceuticals
• 7.6: Merz Pharma
• 7.7: Hugel
• 7.8: Evolus
• 7.9: Medytox
• 7.10: Croma-Pharma